trifluridine has been researched along with Leukemia L 1210 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; Bentrude, WG; Béres, J; De Clercq, E; Otvös, L; Sági, G | 1 |
| Gao, YS; Lin, TS | 1 |
| ANDERSON, SW; HEIDELBERGER, C | 1 |
| Hayatsu, H; Matsumoto, H; Satake, H; Takeda, S; Unemi, N; Wataya, Y; Wierzba, K; Yamada, Y; Yamashita, J | 1 |
| Hayatsu, H; Saito, H; Satake, H; Takeda, S; Uchida, J; Unemi, N; Wataya, Y; Yamada, Y; Yamashita, J | 1 |
5 other study(ies) available for trifluridine and Leukemia L 1210
| Article | Year |
|---|---|
Synthesis and antitumor and antiviral properties of 5-halo- and 5-(trifluoromethyl)-2'-deoxyuridine 3',5'-cyclic monophosphates and neutral triesters.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Cell Line; Deoxyuracil Nucleotides; Drug Evaluation, Preclinical; Humans; Hydrocarbons, Halogenated; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Simplexvirus; Structure-Activity Relationship; Vaccinia virus; Vesicular stomatitis Indiana virus | 1986 |
Synthesis and biological activity of 5-(trifluoromethyl)- and 5-(pentafluoroethyl)pyrimidine nucleoside analogues.
Topics: Animals; Cell Division; Cell Line; Dose-Response Relationship, Drug; Haplorhini; Kidney; Leukemia L1210; Mice; Pyrimidine Nucleosides; Sarcoma 180; Simplexvirus | 1983 |
FLUORINATED PYRIMIDINES. XXI. THE TUMOR-INHIBITORY ACTIVITY OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.
Topics: Animals; Bone Marrow; Carcinoma; Carcinoma, Ehrlich Tumor; Gastrointestinal Tract; Leukemia L1210; Leukopenia; Ligases; Mice; Neoplasms; Pharmacology; Pyrimidines; Rats; Research; Sarcoma 180; Toxicology; Trifluridine; Uracil Nucleotides | 1964 |
Potentiation of the antitumor activity of 5-trifluoromethyl-2'-deoxyuridine by the use of depot forms of the parent compound.
Topics: Animals; Antineoplastic Agents; Cell Division; Delayed-Action Preparations; HeLa Cells; Humans; Leukemia L1210; Male; Mice; Sarcoma 180; Therapeutic Equivalency; Thymidylate Synthase; Trifluridine | 1992 |
Antitumor activity of FTC-092, a masked 5-trifluoromethyl-2'-deoxyuridine derivative.
Topics: Administration, Oral; Animals; Drug Administration Schedule; Drug Screening Assays, Antitumor; Leukemia L1210; Male; Mice; Mice, Inbred ICR; Sarcoma 180; Trifluridine | 1991 |